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S U M M A R Y
The objective of the present report was to review brieﬂy the potentially community-acquired
Acinetobacter baumannii infections, to update information on the reservoirs of A. baumannii outside the
hospital, and to consider their potential interactions with human infections. Most reports on potentially
community-acquired A. baumannii have been published during the last 15 years. They concern
community-acquired pneumonia, infections in survivors from natural disasters, and infected war
wounds in troops from Iraq and Afghanistan. Although the existence of extra-hospital reservoirs of A.
baumannii has long been disputed, the recent implementation of molecular methods has allowed the
demonstration of the actual presence of this organism in various environmental locations, in human
carriage, in pets, slaughter animals, and human lice. Although the origin of the A. baumannii infections in
soldiers injured in Southwestern Asia is difﬁcult to determine, there are some arguments to support the
involvement of extra-hospital reservoirs in the occurrence of community-acquired infections. Overall,
the emergence of community-acquired A. baumannii infections could be associated with interactions
between animals, environment, and humans that are considered to be potentially involved in the
emergence or re-emergence of some infectious diseases.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Acinetobacter baumannii has emerged as an important nosoco-
mial pathogen, and nosocomial infection with this organism has
been associated with increased patient morbidity, mortality, and
health care costs.1–3 Recent studies have improved our knowledge
about the virulence of A. baumannii by using animal models,
adherence to cell cultures, and phenotypic and molecular studies
of the bacteria.4–10 This organism has been responsible for
numerous hospital outbreaks, presents a remarkable ability to
upregulate or acquire resistance determinants,11 and has a
remarkable ability to survive for prolonged periods throughout
the hospital environment,12–14 which can be involved in the
duration of certain outbreaks,15 some of them lasting several
years.16 The cross-transmission of this organism from patient to
patient and the possibility of outbreak extension by patient
transfer has been demonstrated.17 In contrast, the existence of an* Corresponding author. Tel.: +33 241 35 33 15; fax: +33 241 35 41 64.
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potential reservoir in the occurrence of certain infections due to
this organism are still controversial.12,18 It is well established that
the members of the genus Acinetobacter are considered ubiquitous
microorganisms. However, according to most authors, A. bauman-
nii being considered ubiquitous or highly prevalent in nature is an
important misconception due to the difﬁculties encountered in
accurately identifying this organism.12,18
The implementation of molecular methods (e.g. identiﬁcation
of the blaOXA-51-like gene by PCR, or the rpoB gene by sequencing)
has recently improved the identiﬁcation of A. baumannii.19,20
The objective of the present report was to review brieﬂy the
potentially community-acquired A. baumannii infections, to
update information on the reservoirs of A. baumannii outside the
hospital, and to consider their potential interactions with human
infections.
2. Potentially community-acquired A. baumannii infections
Although the ﬁrst reports of respiratory community-acquired
Acinetobacter infections were published in 1977 in two alcoholicses. Published by Elsevier Ltd. All rights reserved.
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concerning potentially community-acquired A. baumannii infec-
tions have been published during the last 15 years.
A. baumannii is increasingly recognized as an uncommon but
important cause of community-acquired pneumonia.23–26 In
addition, most of these infections have occurred during the
warmest and wettest seasons.26 This strongly marked seasonal and
geographical distribution could be related to some climatic or
environmental features involved in the acquisition of these
bacteria by patients. Other studies have demonstrated summer
peaks and temperature-associated increases in Gram-negative
infections among hospitalized patients.27,28 According to a time-
series analysis reported in a study conducted at the University of
Maryland Medical Center, the increase in the monthly A. baumannii
infection rate was 17% for each 10 8F increase in outdoor
temperatures.27 According to Anstey et al.,23 community-acquired
pneumonia could occur following microaspiration of A. baumannii
in patients with preceding throat colonization with this species.
A. baumannii is one of the microorganisms that are most
commonly isolated in wound cultures from survivors of natural
disasters. It has been demonstrated in earthquakes29,30 and a
tsunami.31 In the Wenchuan (China) earthquake that occurred in
2008, A. baumannii was isolated from wounds, sputum, and blood
of some injured persons.30
Since 2003 the incidence of A. baumannii infection in US military
hospitals has increased, primarily among wounded troops from
Southwest Asia.32 A microbiological study concerning war wounds
in US troops from Iraq and Afghanistan upon arrival at the National
Naval Medical Center (USA) demonstrated that A. baumannii was
the most prevalent organism isolated, representing 63.0% of all
isolates.33 Similarly, bacteria belonging to the A. calcoaceticus–
baumannii complex (ABC) were the most prevalent microorgan-
isms isolated in the cultures obtained from casualties coming from
Iraq and Afghanistan who had open tibial fractures that were
complicated by infection.34
Overall, studies reporting community-acquired A. baumannii
infections are based on single events or case series. It is noticeable
that, to the best of our knowledge, no study estimating the
evolution of the incidence of community-acquired A. baumannii
infections has been published. Moreover, in most published
studies, details concerning the methods used for bacterial
identiﬁcation are limited. Considering the difﬁculties encoun-
tered in the identiﬁcation of A. baumannii, this lack of information
is an important limitation for the interpretation of those study
results.
3. Extra-hospital reservoirs of A. baumannii
A. baumannii has been isolated from various environmental
locations. Indeed, it has been recovered from soil contaminated
with petroleum hydrocarbons in countries presenting different
climatic conditions, like India35 and France.36 A lot of Acinetobacter
species, including A. baumannii, are able to degrade diesel fuel.37
Among 66 soil samples analyzed in Hong Kong, more than a third
contained Acinetobacter sp, with A. baumannii representing 23% of
these bacteria.38 A. baumannii has also been isolated from
vegetables collected in supermarkets, greengrocers, and private
gardens.39 Lastly, a recent study conducted in South Korea
recorded the presence of A. baumannii on inanimate surfaces that
are often in contact with humans, like tables in parks and a game
console.40 A. baumannii was also recovered from manured
agricultural soil and pig slurry in the UK,41 and in aquaculture
environments (ﬁsh and shrimp farms) in Southeast Asia.42 It is
noticeable that for all these environmental studies, molecular
techniques for identiﬁcation (ampliﬁed ribosomal DNA restriction
analysis and analysis of the 16S rRNA gene) were used.Data concerning human community carriage of A. baumannii
are scarce. A study performed in New York City reported that 10.4%
of community residents carried A. baumannii on their hands.43 A
prevalence study conducted among 102 healthy nondeployed US
Army soldiers in training reported that 17 individuals (17%) carried
ABC on their skin (forehead or feet).44 Concurrently, a study
performed by the same authors among US Army soldiers stationed
in Iraq failed to ﬁnd any skin carrier.45 Previous surveys in Europe
have also found the rates of A. baumannii skin carriage to be very
low (<1%).46,47
During the last decade, A. baumannii strains have been isolated
from animals. Most of the studies reporting animal cases have been
conducted in veterinary clinics or hospitals.48–51 Nosocomial
spread has been described.49 The A. baumannii infections were
reported in horses and pets, with a slight predominance in wound
infections and abscesses. For those studies performed in animal
health care settings, it is difﬁcult to demonstrate the extra-hospital
origin of A. baumannii. However animals can still be colonized after
discharge, then constituting a reservoir for potential transmissions
to the environment, other animals, or humans.
In a study conducted in Scotland,52 pigs and cattle slaughtered
for human consumption and coming from different farms were
sampled (feces, skin, nostril, ear) for A. baumannii isolation. The
prevalence of A. baumannii carriage was 1.2%. The 16 A. baumannii
isolated were grouped into three different clusters, but had
different pulsed-ﬁeld gel electrophoresis (PFGE) patterns com-
pared with human isolates of the three major European clones ECI,
ECII, and ECIII. Multi-resistant strains have been identiﬁed in other
studies. Zordan et al.53 reported that the 56 A. baumannii isolates
obtained from several German veterinary clinics were highly
resistant to antibiotics, a large proportion of them were genetically
congruent with the European clones I, II, or III, and most of them
belonged to the same cluster. These ﬁndings indicate that, as in
human medicine, A. baumannii is also an emerging opportunistic
pathogen in veterinary medicine, especially in hospitalized
animals. However, no cohort or case–control study has investigat-
ed if contact of humans with animals increases the risk of acquiring
A. baumannii infections.
Apart from vertebrate animals, A. baumannii strains have also
been identiﬁed in human lice. La Scola and Raoult54 demonstrated
that the average prevalence of A. baumannii DNA among 622 body
lice sampled from various continents (Europe, Africa, and South
America) varied with a range from 3% to 58%. A recent study
conducted in Ethiopia showed the presence of A. baumannii in
human body lice and also head lice.55 In another recent study
conducted in Paris,56 A. baumannii was isolated in 33% of head lice
from elementary schoolchildren. However, whether lice could be a
preferential host for A. baumannii has not been established.
4. Potential interactions between extra-hospital reservoirs and
infections
According to a study recorded in Singapore, A. baumannii was
found to colonize burns very early in the course of the infected
patient’s hospital stay (median 2 days).57 Therefore, the importa-
tion from the community of some A. baumannii strains by the
patient is a possibility not to be overlooked. This hypothesis is also
supported by the small size of the outbreaks that occurred in this
unit during the study. Indeed, the largest one included only ﬁve
patients, indicating a low level of cross-transmission. Moreover,
this outbreak could be traced to a patient following the Jakarta
Marriott terrorist bombing, underscoring its community origin.57
The origin of the A. baumannii infections in soldiers injured in
Afghanistan and Iraq is difﬁcult to determine. The infections may
have been acquired from environmental sources in the ﬁeld, during
evacuation from the operating theatres to the military ﬁeld
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at hospitals after evacuation outside of the conﬂict area. In a study
of skin and soft tissue infections due to A. baumannii identiﬁed
among American soldiers and Iraqi nationals in a hospital ship, the
mean time to diagnosis of the infection was 12.8 days, a duration
that is more consistent with nosocomial acquisition.58 Based on
the absence of a correlation between the geographic location of the
traumatic injury and the genotype of A. baumannii, Petersen et al.
suggested that the environment at the time of wounding was an
unlikely source of infection.59 Concurrently, several studies
showed that at the time of presentation to the hospital, higher
rates of multi-resistant ABC infections or colonizations were
observed in the Iraqi non-US patient population than in US
patients.60–62 The observations of Ake et al., which were recorded
at the beginning of the casualty evacuation chain, suggest that
multi-resistant ABC colonization or infection of host nation
patients exists before their entry into deployed US military
facilities. Therefore, this could at least partially reﬂect community
carriage of these organisms.60
The role of a previous colonization with A. baumannii in the
development of community-acquired infections is supported by
the difference in rates of A. baumannii carriage identiﬁed in non-
hospitalized patients (some high rates of skin carriage (4%)
during the wet and warm season in Hong Kong63 as compared to
the low rates (<1%) of skin or fecal colonization described in
Europe), which is consistent with the seasonal differences
recorded for community-acquired A. baumannii pneumonia in
Southeast Asia and their scarcity or their absence in Europe.
Further studies are needed to determine whether lice can
act as a hidden extra-human reservoir for bacteria and can
promote the spread of A. baumannii among humans. In a
broader perspective, it would be useful to study the potential
role of other vectors (cockroaches, ﬂies, etc.) in A. baumannii
transmission.
The presence of strains belonging to the European clones I–III in
animals raises concerns about the possibility of spread from
humans to animals and vice versa. In addition, PCR and DNA
sequencing for various genes of resistance to antibiotics demon-
strated that the molecular backgrounds of resistance to amino-
glycosides and quinolones and the hyperproduction of
chromosomal beta-lactamases had patterns common to those
described in A. baumannii of human origin.52
In conclusion, it has been demonstrated by molecular
identiﬁcation that A. baumannii is actually present outside the
hospital. Several arguments are consistent with the involvement of
extra-hospital reservoirs of A. baumannii in the occurrence of
community-acquired infections. However additional studies are
needed for a better estimation of the incidence of community-
acquired A. baumannii infections and a better understanding of the
mechanisms of interactions between the different potential
reservoirs and humans.
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